Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure ...

The package lay open on my kitchen table – a collection of syringes and a small, unmarked glass vial containing what was supposedly semaglutide, the key ingredient of the blockbuster weight-loss drugs ...

This marks the regulator's second backing for a use of Wegovy beyond weight loss and further strengthens Novo's case that the ...

For those looking to explore semaglutide and maximize its benefits, incorporating a balanced exercise routine is key. A ...

Below, check out the roundup of California Healthline’s coverage. For today's national health news, read KFF Health News’ Morning Briefing.

WASHINGTON (NEXSTAR) — Americans face a hefty price tag for diabetes and weight-loss drugs. “The people of the United States ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with ...

Businesses can take proactive steps now to best position themselves for a competitive advantage in the face of the seismic ...

A first-of-its-kind analysis conducted as part of an investigation by journalists in eight countries found that some of the ...